NCT07043153 AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
| NCT ID | NCT07043153 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Systemic Lupus Erythematosus Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-08-05 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.
Eligibility Criteria
Inclusion Criteria: * · Age ≥ 18 years. * Both sexes. * Patients diagnosed with SLE who fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria and matched controls. Exclusion Criteria: * Co-existing chronic inflammatory or autoimmune diseases. * Age \<18 years * Malignancy. * Pregnancy or lactation. * Chronic liver or renal insufficiency. * Malignant hematologic diseases. * Active hepatitis. * Acute infection within the previous four weeks
Contact & Investigator
Esam M Abualfadl, Professor
STUDY CHAIR
Sohag University
Frequently Asked Questions
Who can join the NCT07043153 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Systemic Lupus Erythematosus Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07043153 currently recruiting?
Yes, NCT07043153 is actively recruiting participants. Contact the research team at Hala.hamed@med.sohag.edu.eg for enrollment information.
Where is the NCT07043153 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07043153 clinical trial?
NCT07043153 is sponsored by Sohag University. The principal investigator is Esam M Abualfadl, Professor at Sohag University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.